31-Gene Expression Profile Testing Survival Benefit in a Population-based Analysis of Cutaneous Melanoma Patients ≥65 Years of Age. J of Skin [Internet]. 2022 Mar. 4 [cited 2025 May 18];6(2):s24. Available from: https://skin.dermsquared.com/skin/article/view/1541